Caterpillar, Microsoft Share Losses Lead Dow's 100-Point Drop
Jefferies Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $380
These 10 Drugs Will Be Cheaper After Medicare Negotiations
US Drug Price Measure to Cut Costs by $7.5 Billion in 2026
10 Health Care Stocks With Whale Alerts In Today's Session
Big Pharma: The Government Revealed Its List of Negotiated Drug Prices. Here Are the Reactions.
Medicare's New Drug Prices Are Out. They Aren't So Bad for Drugmakers
Biden Administration Releases Prices of 10 Drugs in Medicare Negotiations
TD Cowen Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $381
U.S. Announces Final Drug Prices After Medicare Negotiations
U.S. Government Targets $6B in Saving From First Medicare Drug Price Negotiations
Express News | U.S. CMS: When Negotiated Prices Go Into Effect in 2026, People Enrolled in Medicare Prescription Drug Coverage Would Save Estimated $1.5 Bln
Express News | U.S. CMS: Agreed to Negotiated Price for 30- Day Supply for Cy 2026 for Enbrel Is $2,355.00
Amgen To Go Ex-Dividend On August 16th, 2024 With 2.25 USD Dividend Per Share
The 28 Companies in BMO Capital's High-quality Stock Screen
Amgen Inc. (AMGN): Pioneering Healthcare Innovations in Obesity Treatment
Earnings Troubles May Signal Larger Issues for Amgen (NASDAQ:AMGN) Shareholders
Daiwa Securities Adjusts Price Target on Amgen to $351 From $350, Maintains Buy Rating
Smart Money Is Betting Big In AMGN Options
Amgen (AMGN.US) and Astrazeneca (AZN.US) received breakthrough therapy designation from the FDA for their first-in-class therapy for treating COPD.
Two companies are planning to launch phase III clinical trials in COPD patients.